The Neuropathic Pain Market is projected to witness significant growth, with a compound annual growth rate (CAGR) of 5.19%. Expected to expand from USD 7.8 billion in 2024 to approximately USD 16.62 billion by 2035, the market dynamics are heavily influenced by a rising prevalence of diabetic neuropathy, which alone commands a 54% share of the market. This growth trajectory suggests a robust...